<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38592290</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>02</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Co-Morbidity Clusters in Post-COVID-19 Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1457</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13051457</ELocationID><Abstract><AbstractText><b>Background:</b> Post-COVID-19 syndrome, characterized by persistent symptoms emerging more than 12 weeks after acute infection, displays diverse manifestations. This study aimed to analyze co-existing organ dysfunctions in post-COVID-19 patients and explore their potential association with the acute COVID-19 episode and functional impairment. <b>Methods:</b> Data from 238 patients attending post-COVID-19 outpatient care between 1 March 2021 and 1 March 2022, after previous hospitalization for acute COVID-19, were retrospectively analyzed with 80 having comprehensive mapping of organ involvement. <b>Results:</b> The average time between acute episode and post-COVID-19 care was 149 days. Spirometry indicated significant abnormalities in lung function. Predominant symptoms included respiratory (75%), fatigue (73%), neurological (62.5%), and ear-nose-throat issues (51.25%). Multiorgan dysfunctions were observed in 87.5% of patients, contributing to an 18.33% reduction in health quality compared to pre-acute COVID-19 levels. Subgroup analysis identified four distinct post-COVID-19 syndrome subgroups, highlighting the coexistence of respiratory and neurological disorders as potential indicators and drivers of further organ involvement. Our results reveal that most patients with post-COVID-19 syndrome suffer from multiorgan disorders. <b>Conclusions:</b> The presence of coexisting respiratory and neurological symptoms suggests the involvement of other organ systems as well. The complexity of multiorgan involvement requires further studies to provide insights into the different symptom clusters and identify potential targets for personalized preventive and therapeutic interventions to improve patient outcome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xe1;rk&#xf6;zi</LastName><ForeName>Anna Ter&#xe9;z</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tornyi</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-2165-4196</Identifier><AffiliationInfo><Affiliation>Department of Pulmonology, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe9;k&#xe9;si</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horv&#xe1;th</LastName><ForeName>Ildik&#xf3;</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University of Debrecen, 4032 Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Koranyi Institute of Pulmonology, 1121 Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">multidisciplinary team</Keyword><Keyword MajorTopicYN="N">multiorgan syndrome</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38592290</ArticleId><ArticleId IdType="pmc">PMC10934165</ArticleId><ArticleId IdType="doi">10.3390/jcm13051457</ArticleId><ArticleId IdType="pii">jcm13051457</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  Post COVID-19 Condition (Long COVID)  [(accessed on 22 December 2023)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Wise J. COVID-19: WHO urges action as 17 million long Covid cases are estimated in Europe. BMJ. 2022;378:o2232. doi: 10.1136/bmj.o2232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o2232</ArticleId><ArticleId IdType="pubmed">36104031</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M., Mudara C., Vika C., Blumberg L., Mayet N., Cohen C., Tempia S., Parker A., Nel J., Perumal R., et al. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: A prospective cohort study. Lancet Glob. Health. 2022;10:e1247&#x2013;e1256. doi: 10.1016/S2214-109X(22)00286-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., Shoenfeld Y. Post-COVID syndrome: The aftershock of SARS-CoV-2. Int. J. Infect. Dis. 2022;114:233&#x2013;235. doi: 10.1016/j.ijid.2021.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.020</ArticleId><ArticleId IdType="pmc">PMC8590600</ArticleId><ArticleId IdType="pubmed">34785367</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S.J., Baldwin M.M., Daynes E., Evans R.A., Greening N.J., Jenkins R.G., Lone N.I., McAuley H., Mehta P., Newman J., et al. Respiratory sequelae of COVID-19: Pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir. Med. 2023;11:709&#x2013;725. doi: 10.1016/S2213-2600(23)00159-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00159-5</ArticleId><ArticleId IdType="pmc">PMC10198676</ArticleId><ArticleId IdType="pubmed">37216955</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrobaa I.H., New K.J. COVID-19: Pulmonary and extra pulmonary manifestations. Front. Public Health. 2021;9:711616. doi: 10.3389/fpubh.2021.711616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.711616</ArticleId><ArticleId IdType="pmc">PMC8505777</ArticleId><ArticleId IdType="pubmed">34650947</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., McCracken C., Cassar M.P., Moss A.J., Finnigan L., Samat A.H., Ogbole G., Tunnicliffe E.M., Alfaro-Almagro F., Menke R., et al. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): A prospective, multicentre, observational cohort study. Lancet Respir. Med. 2023;11:1003&#x2013;1019. doi: 10.1016/S2213-2600(23)00262-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00262-X</ArticleId><ArticleId IdType="pmc">PMC7615263</ArticleId><ArticleId IdType="pubmed">37748493</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A review of persistent post-COVID syndrome (PPCS) Clin. Rev. Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S., Zechmeister-Koss I., Erd&#xf6;s J. Possible long COVID healthcare pathways: A scoping review. BMC Health Serv. Res. 2022;22:1076. doi: 10.1186/s12913-022-08384-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08384-6</ArticleId><ArticleId IdType="pmc">PMC9396575</ArticleId><ArticleId IdType="pubmed">35999605</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D., Savale L., Beurnier A., Colle R., No&#xeb;l N., Pham T., Monnet X., Humbert M. Multidisciplinary approach for post-acute COVID-19 syndrome: Time to break down the walls. Eur. Respir. J. 2021;58:2101090. doi: 10.1183/13993003.01090-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01090-2021</ArticleId><ArticleId IdType="pmc">PMC8112007</ArticleId><ArticleId IdType="pubmed">33958429</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P.W., Tabberer M., Chen W.H. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT&#x2122;) scores. BMC Pulm. Med. 2011;11:42. doi: 10.1186/1471-2466-11-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2466-11-42</ArticleId><ArticleId IdType="pmc">PMC3199910</ArticleId><ArticleId IdType="pubmed">21835018</ArticleId></ArticleIdList></Reference><Reference><Citation>GlaxoSmithKline  COPD Assessment Test (CAT)  [(accessed on 20 December 2023)].  Available online:  https://www.catestonline.org/patient-site-test-page-hungarian.html.</Citation></Reference><Reference><Citation>Daynes E., Gerlis C., Briggs-Price S., Jones P., Singh S.J. COPD assessment test for the evaluation of COVID-19 symptoms. Thorax. 2020;76:185&#x2013;187. doi: 10.1136/thoraxjnl-2020-215916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215916</ArticleId><ArticleId IdType="pubmed">33148809</ArticleId></ArticleIdList></Reference><Reference><Citation>GlaxoSmithKline  COPD Assessment Test (CAT)  [(accessed on 14 February 2024)].  Available online:  https://www.catestonline.org/patient-site-test-page-english.html.</Citation></Reference><Reference><Citation>Dolan P., Sutton M. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc. Sci. Med. 1997;44:1519&#x2013;1530. doi: 10.1016/S0277-9536(96)00271-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0277-9536(96)00271-7</ArticleId><ArticleId IdType="pubmed">9160441</ArticleId></ArticleIdList></Reference><Reference><Citation>Shmueli A. The visual analog rating scale of health-related quality of life: An examination of end-digit preferences. Health Qual. Life Outcomes. 2005;3:71. doi: 10.1186/1477-7525-3-71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-3-71</ArticleId><ArticleId IdType="pmc">PMC1308843</ArticleId><ArticleId IdType="pubmed">16285884</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health  COVID-19 Treatment Guidelines: Clinical Spectrum of SARS-CoV-2 Infection.  [(accessed on 20 February 2024)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Yang X., Hou C., Shen Y., Zhang M., Zhang K., Wang F., Liu Y., Ma X., Cheng L., Kang J., et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw. Open. 2022;5:e2231790. doi: 10.1001/jamanetworkopen.2022.31790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31790</ArticleId><ArticleId IdType="pmc">PMC9478774</ArticleId><ArticleId IdType="pubmed">36107425</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Sol&#xed;s-Navarro L., Burgos F., Puppo H., Vilar&#xf3; J. Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis. Pulmonology. 2021;27:328&#x2013;337. doi: 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Abou Shaar B., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q., Li J., Hu X., Bai Y., Zheng Y., Gao Z. Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: A systematic review and meta-analysis. Front. Med. 2021;8:702635. doi: 10.3389/fmed.2021.702635.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.702635</ArticleId><ArticleId IdType="pmc">PMC8448290</ArticleId><ArticleId IdType="pubmed">34540862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocanu A., Lazureanu V.E., Laza R., Marinescu A.R., Cut T.G., Sincaru S.V., Marza A.M., Popescu I.M., Herlo L.F., Nelson-Twakor A., et al. Laboratory Findings and Clinical Outcomes of ICU-Admitted COVID-19 Patients: A Retrospective Assessment of Particularities Identified among Romanian Minorities. J. Pers. Med. 2023;13:195. doi: 10.3390/jpm13020195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13020195</ArticleId><ArticleId IdType="pmc">PMC9967597</ArticleId><ArticleId IdType="pubmed">36836429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzalai E., Giannini D., Tosti M.E., D&#x2019;Angelo F., Declich S., Jaljaa A., Caminada S., Turatto F., De Marchi C., Gatta A., et al. Risk of COVID-19 Severe Outcomes and Mortality in Migrants and Ethnic Minorities Compared to the General Population in the European WHO Region: A Systematic Review. J. Int. Migr. Integr. 2023;24:1305&#x2013;1335. doi: 10.1007/s12134-023-01007-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12134-023-01007-x</ArticleId><ArticleId IdType="pmc">PMC9833641</ArticleId><ArticleId IdType="pubmed">36647529</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C., Bellmann-Strobl J.T., Heindrich C., Wittke K., Stein E., Franke C., Pr&#xfc;ss H., Pre&#xdf;ler H., Machule M.L., Audebert H., et al. Fighting Post-COVID and ME/CFS&#x2013;development of curative therapies. Front. Med. 2023;10:1194754. doi: 10.3389/fmed.2023.1194754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1194754</ArticleId><ArticleId IdType="pmc">PMC10309204</ArticleId><ArticleId IdType="pubmed">37396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula S.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Kamal M.A., Staines D.R., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott N.A., Pearmain L., Knight S.B., Brand O., Morgan D.J., Jagger C., Harbach S., Khan S., Shuwa H.A., Franklin M., et al. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur. Respir. J. 2023;61:2202226. doi: 10.1183/13993003.02226-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F., Efstathiou C., Openshaw P.J. Long COVID: Clues about causes. Eur. Respir. J. 2023;61:2300409. doi: 10.1183/13993003.00409-2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00409-2023</ArticleId><ArticleId IdType="pmc">PMC10040855</ArticleId><ArticleId IdType="pubmed">36958743</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikl&#xf3;s Z., Horv&#xe1;th I. The Role of Oxidative Stress and Antioxidants in Cardiovascular Comorbidities in COPD. Antioxidants. 2023;12:1196. doi: 10.3390/antiox12061196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12061196</ArticleId><ArticleId IdType="pmc">PMC10295232</ArticleId><ArticleId IdType="pubmed">37371927</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund O., Breslavsky A., Fried S., Givoli-Vilensky R., Cohen-Rubin S., Zacks N., Kleinhendler E., Unterman A., Frydman S., Wand O., et al. Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19. Clin. Exp. Med. 2023;23:3729&#x2013;3736. doi: 10.1007/s10238-023-01139-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01139-5</ArticleId><ArticleId IdType="pubmed">37479879</ArticleId></ArticleIdList></Reference><Reference><Citation>Freund O., Breslavsky A., Givoli-Vilensky R., Zacks N., Gershman E., Melloul A., Wand O., Bilenko N., Bar-Shai A. Assessment of a close respiratory follow-up schedule at 3 and 6 months after acute COVID-19 and its related investigations. Respir. Med. 2023;217:107367. doi: 10.1016/j.rmed.2023.107367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2023.107367</ArticleId><ArticleId IdType="pubmed">37479120</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong C.M., Le Y.J., Boon G.J., Barco S., Klok F.A., Siegerink B. Eight lessons from 2 years of use of the Post-COVID-19 Functional Status scale. Eur. Respir. J. 2023;61:2300416. doi: 10.1183/13993003.00416-2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00416-2023</ArticleId><ArticleId IdType="pmc">PMC10151454</ArticleId><ArticleId IdType="pubmed">37080570</ArticleId></ArticleIdList></Reference><Reference><Citation>Trongtrakul K., Tajarernmuang P., Limsukon A., Theerakittikul T., Niyatiwatchanchai N., Surasit K., Glunriangsang P., Liwsrisakun C., Bumroongkit C., Pothirat C., et al. The National Early Warning Score 2 with Age and Body Mass Index (NEWS2 Plus) to Determine Patients with Severe COVID-19 Pneumonia. J. Clin. Med. 2024;13:298. doi: 10.3390/jcm13010298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13010298</ArticleId><ArticleId IdType="pmc">PMC10780151</ArticleId><ArticleId IdType="pubmed">38202305</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.J., Seo Y.B., Seo J.W., Lee J., Nham E., Seong H., Yoon J.G., Noh J.Y., Cheong H.J., Kim W.J., et al. Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023;12:7375. doi: 10.3390/jcm12237375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12237375</ArticleId><ArticleId IdType="pmc">PMC10707593</ArticleId><ArticleId IdType="pubmed">38068427</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliano M., Tiple D., Agostoni P., Armocida B., Biardi L., Bonfigli A.R., Campana A., Ciardi M., Di Marco F., Floridia M., et al. Italian good practice recommendations on management of persons with Long-COVID. Front. Public Health. 2023;11:1122141. doi: 10.3389/fpubh.2023.1122141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1122141</ArticleId><ArticleId IdType="pmc">PMC10157646</ArticleId><ArticleId IdType="pubmed">37151592</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry M.A., Berg R.M., Shelley J., Hudson J., Saynor Z.L., Duckers J., Lewis K., Davies G.A., Mackintosh K.A. Inspiratory muscle training enhances recovery post-COVID-19: A randomised controlled trial. Eur. Respir. J. 2022;60:2103101. doi: 10.1183/13993003.03101-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee Y.J., Fan B.E., Young B.E., Dalan R., Lye D.C. Clinical trials on the pharmacological treatment of long COVID: A systematic review. J. Med. Virol. 2023;95:e28289. doi: 10.1002/jmv.28289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Leber A., Jawad M.Y., Yu M., Lui L.M., Subramaniapillai M., Di Vincenzo J.D., Gill H., Rodrigues N.B., Cao B., et al. Registered clinical trials investigating treatment of long COVID: A scoping review and recommendations for research. Infect. Dis. 2022;54:467&#x2013;477. doi: 10.1080/23744235.2022.2043560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId><ArticleId IdType="pmc">PMC8935463</ArticleId><ArticleId IdType="pubmed">35282780</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Yon D.K., Lee S.W., Soysal P., Koyanagi A., Jacob L., Li Y., Park J.M., Kim Y.W., Shin J.I., et al. New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis. J. Med. Virol. 2023;95:e28909. doi: 10.1002/jmv.28909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28909</ArticleId><ArticleId IdType="pubmed">37394783</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>